Lungpacer Medical Nominated for 2026 Prix Galien USA Award for Best Medical Technology
· Financial Post
Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again Read More
Visit betsport.cv for more information.